182
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months

, , , ORCID Icon, ORCID Icon & ORCID Icon
Pages 363-371 | Received 26 Jun 2018, Accepted 09 Jul 2018, Published online: 25 Sep 2018

References

  • Hatzaki A, Sifakis S, Apostolopoulou D, Bouzarelou D, Konstantinidou A, Kappou D, Sideris A, Tzortzis E, Athanassiadis A, Florentin L, et al. FGFR3 related skeletal dysplasias diagnosed prenatally by ultrasonography and molecular analysis: presentation of 17 cases. Am J Med Genet A. 2011;155A(10):2426–35. doi:10.1002/ajmg.a.34189.
  • Hevner RF. The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis. Acta Neuropathol. 2005;110(3):208–21.
  • Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59. doi:10.1186/1471-2431-13-59
  • Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide AL, Maroteaux P, Bonaventure J, Narcy F, Sanak M. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet. 1995;10:11–2. doi:10.1038/ng0595-11
  • Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat. 2012;33(1):29–41. doi:10.1002/humu.21636.
  • Superti-Furga A, Unger S. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A. 2007;143A(1):1–18.
  • Wilkie AO. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 2005;16(2):187–203.
  • Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet. 1995;9:321–8.
  • Maroteaux PLM, Robert JM. [Thanatophoric dwarfism]. Presse Med. 1967;75:2519–24.
  • Langer LO Jr, Yang SS, Hall JG, Sommer A, Kottamasu SR, Golabi M, Krassikoff N. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl. 1987;3:167–79.
  • Isaacson G, Blakemore KJ, Chervenak FA. Thanatophoric dysplasia with cloverleaf skull. Am J Dis Child. 1983;137:896–8.
  • Osoba O, Aziz NL, Krishnamoorthy U. Review of the diagnosis and transmission of thanatophoric dysplasia and report of a familial case with three affected siblings. J Obstet Gynaecol. 2000;20(5):540–1. doi:10.1080/014436100434857.
  • Partington MW, Gonzales-Crussi F, Khakee SG, Wollin DG. Cloverleaf skull and thanatophoric dwarfism. Report of four cases, two in the same sibship. Arch Dis Child. 1971;46:656–64.
  • Wilcox WR, Tavormina PL, Krakow D, Kitoh H, Lachman RS, Wasmuth JJ, Thompson LM, Rimoin DL. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet. 1998;78:274–81.
  • Johnson A, Callan NA, Bhutani VK, Colmorgen GHC, Weiner S, Bolognese RJ. Ultrasonic ratio of fetal thoracic to abdominal circumference: an association with fetal pulmonary hypoplasia. Am J Obstet Gynecol. 1987;157(3):764–9.
  • Rahemtullah A, McGillivray B, Wilson RD. Suspected skeletal dysplasias: femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome. Am J Obstet Gynecol. 1997;177:864–9.
  • Vogt C, Blaas HG. Thanatophoric dysplasia: autopsy findings over a 25-year period. Pediatr Dev Pathol. 2013;16:160–167.
  • Wongmongkolrit T, Bush M, Roessmann U. Neuropathological findings in thanatophoric dysplasia. Arch Pathol Lab Med. 1983;107:132–5.
  • Goutières F, Aicardi J, Farkas-Bargeton E. An unusual cerebral malformation associated with thanatophoric dwarfism. Rev Neurol (Paris). 1971;125:435–40.
  • Stensvold K, Ek J, Hovland AR. An infant with thanatophoric dwarfism surviving 169 days. Clin Genet. 1986;29:157–9.
  • Tonoki H. A boy with thanatophoric dysplasia surviving 212 days. Clin Genet. 1987;32(6):415–6.
  • Noe EJ, Yoo HW, Kim KN, Lee SY. A case of thanatophoric dysplasia type I with an R248C mutation in the FGFR3 gene. Korean J Pediatr. 2010;53(12):1022–5. doi:10.3345/kjp.2010.53.12.1022.
  • Nakai K, Yoneda K, Moriue T, Munehiro A, Fujita N, Moriue J, Yokoi I, Haba R, Itoh S, Kubota Y. Seborrhoeic keratoses and acanthosis nigricans in a long-term survivor of thanatophoric dysplasia. Br J Dermatol. 2010;163(3):656–8. doi:10.1111/j.1365-2133.2010.09879.x.
  • Nikkel SM, Major N, King WJ. Growth and development in thanatophoric dysplasia - an update 25 years later. Clin Case Rep. 2013;1(2):75–8. doi:10.1002/ccr3.29.
  • Sawai H, Komori S, Ida A, Henmi T, Bessho T, Koyama K. Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results. Prenat Diagn. 1999;19:21–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.